Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
2021 · Thorax · 108 citations
https://doi.org/10.1136/thoraxjnl-2021-217260
P
Paul Elkington
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
154
Papers
7.2K
Citations
51
h-index
98
i10-index
Paul Elkington is an academic researcher from NIHR Southampton Respiratory Biomedical Research Unit. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Mycobacterium research and diagnosis & Infectious Diseases and Tuberculosis. The author has an h-index of 51, co-authored 131 publications.
ORCID: 0000-0003-0390-0613Papers by this author
worksHypoxia increases neutrophil-driven matrix destruction after exposure to Mycobacterium tuberculosis
2018 · Scientific Reports · 72 citations
https://doi.org/10.1038/s41598-018-29659-1
Monocyte-Dependent Fibroblast CXCL8 Secretion Occurs in Tuberculosis and Limits Survival of Mycobacteria within Macrophages
2007 · The Journal of Immunology · 65 citations
https://doi.org/10.4049/jimmunol.178.6.3767
Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases
2016 · Respiratory Research · 32 citations
https://doi.org/10.1186/s12931-016-0402-z
Early Secretory Antigenic Target-6 Drives Matrix Metalloproteinase-10 Gene Expression and Secretion in Tuberculosis
2016 · American Journal of Respiratory Cell and Molecular Biology · 27 citations
https://doi.org/10.1165/rcmb.2016-0162oc
Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers
2024 · JCI Insight · 17 citations
https://doi.org/10.1172/jci.insight.173273
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat